United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - thiamine hydrochloride; riboflavin sodium phosphate; dexpanthenol; pyridoxine hydrochloride; nicotinamide - oral solution - 1mg/1ml ; 548microgram/1ml ; 600microgram/1ml ; 400microgram/1ml ; 4mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 100 mg/ml; riboflavine sodium phosphate, quantity: 2 mg/ml; nicotinamide, quantity: 20 mg/ml; dexpanthenol, quantity: 20 mg/ml; pyridoxine hydrochloride, quantity: 40 mg/ml; cyanocobalamin, quantity: 0.4 mg/ml - injection, solution - excipient ingredients: disodium edetate; benzyl alcohol; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7. carpal tunnel syndrome. 8. pernicious anaemia as a result of in situ b12 deficiency. general indications include: 1. angular stomatitis and glossitis have been shown in some instances to respond to t

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 5 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 10 mg/ml; pyridoxine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. patients requiring parenteral b vitamin therapy who cannot tolerate intramuscular injections. 5. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that iv b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 6. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2 and b6. 7. peripheral neuritis caused by vari

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - alpha tocopheryl acetate, cholecalciferol, cyanocobalamin, dexpanthenol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavine sodium phosphate, thiamine hydrochloride - solution for injection - vitamin - horses

United Kingdom - English - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - alpha tocopheryl acetate, cholecalciferol, cyanocobalamin, dexpanthenol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavine sodium phosphate, thiamine hydrochloride -

United Kingdom - English - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - alpha tocopheryl acetate, cholecalciferol, cyanocobalamin, dexpanthenol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavine sodium phosphate, thiamine hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

chem-pharm - vitamin a palmitate ; vitamin d3 ; nicotinamide; dexpanthenol; vitamin b12; vitamin e acetate ; thiamine hydrochloride ; riboflavin sodium phosphate ; pyridoxine - solution for injection - . - combinations of vitamins - cattle, pigs, sheep - vitamins and minerals

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

zenufa laboratories (t) limited, tanzania - vitamin a, thiamine, riboflavin, nicotinamide, ascobic acid , vitamin d3 - syrup - vitamin a bp 2500 iu/5ml, colecalciferol bp 200iu/5ml, thiamine hydrochloride bp 2mg/5ml, riboflavin bp 1mg/5ml, pyridoxine hydrochloride bp 1mg/5ml, cyanocobalamin bp 1mcg/5ml, dexpanthenol bp 2.5mg/5ml, nicotinamide bp 15mg/5ml, ascorbic acid bp 50mg/5m

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

br pharmaceuticals ltd - riboflavin; nicotinamide; thiamine hydrochloride - oral tablet - 1mg ; 15mg ; 1mg